451 related articles for article (PubMed ID: 17517843)
1. Experimental phage therapy against Staphylococcus aureus in mice.
Capparelli R; Parlato M; Borriello G; Salvatore P; Iannelli D
Antimicrob Agents Chemother; 2007 Aug; 51(8):2765-73. PubMed ID: 17517843
[TBL] [Abstract][Full Text] [Related]
2. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.
Matsuzaki S; Yasuda M; Nishikawa H; Kuroda M; Ujihara T; Shuin T; Shen Y; Jin Z; Fujimoto S; Nasimuzzaman MD; Wakiguchi H; Sugihara S; Sugiura T; Koda S; Muraoka A; Imai S
J Infect Dis; 2003 Feb; 187(4):613-24. PubMed ID: 12599078
[TBL] [Abstract][Full Text] [Related]
3. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus.
O'Flaherty S; Coffey A; Meaney W; Fitzgerald GF; Ross RP
J Bacteriol; 2005 Oct; 187(20):7161-4. PubMed ID: 16199588
[TBL] [Abstract][Full Text] [Related]
4. [Combination utility of phages GH15 and K against Staphylococcus aureus].
Liu X; Gu J; Han W; Li Y; Han D; Zhang Q; Lu R; Song J; Feng X; Lei L
Wei Sheng Wu Xue Bao; 2013 May; 53(5):498-506. PubMed ID: 23957155
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages.
Kaur S; Harjai K; Chhibber S
Appl Microbiol Biotechnol; 2014 May; 98(10):4653-61. PubMed ID: 24633444
[TBL] [Abstract][Full Text] [Related]
6. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.
O'Flaherty S; Ross RP; Meaney W; Fitzgerald GF; Elbreki MF; Coffey A
Appl Environ Microbiol; 2005 Apr; 71(4):1836-42. PubMed ID: 15812009
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
Drilling A; Morales S; Jardeleza C; Vreugde S; Speck P; Wormald PJ
Am J Rhinol Allergy; 2014; 28(1):3-11. PubMed ID: 24717868
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains.
Kwiatek M; Parasion S; Mizak L; Gryko R; Bartoszcze M; Kocik J
Arch Virol; 2012 Feb; 157(2):225-34. PubMed ID: 22045271
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
[TBL] [Abstract][Full Text] [Related]
10. Real-time optical detection of methicillin-resistant Staphylococcus aureus using lytic phage probes.
Guntupalli R; Sorokulova I; Krumnow A; Pustovyy O; Olsen E; Vodyanoy V
Biosens Bioelectron; 2008 Sep; 24(1):151-4. PubMed ID: 18424125
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections.
O'Flaherty S; Ross RP; Flynn J; Meaney WJ; Fitzgerald GF; Coffey A
Lett Appl Microbiol; 2005; 41(6):482-6. PubMed ID: 16305674
[TBL] [Abstract][Full Text] [Related]
12. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.
Wills QF; Kerrigan C; Soothill JS
Antimicrob Agents Chemother; 2005 Mar; 49(3):1220-1. PubMed ID: 15728933
[TBL] [Abstract][Full Text] [Related]
13. Wide host range and strong lytic activity of Staphylococcus aureus lytic phage Stau2.
Hsieh SE; Lo HH; Chen ST; Lee MC; Tseng YH
Appl Environ Microbiol; 2011 Feb; 77(3):756-61. PubMed ID: 21148689
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme.
Son JS; Lee SJ; Jun SY; Yoon SJ; Kang SH; Paik HR; Kang JO; Choi YJ
Appl Microbiol Biotechnol; 2010 May; 86(5):1439-49. PubMed ID: 20013118
[TBL] [Abstract][Full Text] [Related]
15. Characterization of methicillin resistant Staphylococcus aureus strains by a set of MRSA phages.
Mathur MD; Mehndiratta PL
Indian J Med Res; 2000 Mar; 111():77-80. PubMed ID: 10937382
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential.
Hoshiba H; Uchiyama J; Kato S; Ujihara T; Muraoka A; Daibata M; Wakiguchi H; Matsuzaki S
Arch Virol; 2010 Apr; 155(4):545-52. PubMed ID: 20224894
[TBL] [Abstract][Full Text] [Related]
17. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.
Paul VD; Sundarrajan S; Rajagopalan SS; Hariharan S; Kempashanaiah N; Padmanabhan S; Sriram B; Ramachandran J
BMC Microbiol; 2011 Aug; 11():195. PubMed ID: 21880144
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15).
O'Neill GL; Murchan S; Gil-Setas A; Aucken HM
J Clin Microbiol; 2001 Apr; 39(4):1540-8. PubMed ID: 11283084
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus Aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants.
Shimamori Y; Mitsunaka S; Yamashita H; Suzuki T; Kitao T; Kubori T; Nagai H; Takeda S; Ando H
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375201
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice.
Sunagar R; Patil SA; Chandrakanth RK
Res Microbiol; 2010 Dec; 161(10):854-60. PubMed ID: 20868746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
